Your browser doesn't support javascript.
loading
Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients.
Ly, K Ina; Richardson, Leland G; Liu, Mofei; Muzikansky, Alona; Cardona, Jonathan; Lou, Kevin; Beers, Andrew L; Chang, Ken; Brown, James M; Ma, Xiaoyue; Reardon, David A; Arrillaga-Romany, Isabel C; Forst, Deborah A; Jordan, Justin T; Lee, Eudocia Q; Dietrich, Jorg; Nayak, Lakshmi; Wen, Patrick Y; Chukwueke, Ugonma; Giobbie-Hurder, Anita; Choi, Bryan D; Batchelor, Tracy T; Kalpathy-Cramer, Jayashree; Curry, William T; Gerstner, Elizabeth R.
Afiliação
  • Ly KI; Stephen E. and Catherine Pappas Center for Neuro-Oncology Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Richardson LG; Department of Neurosurgery Massachusetts General Hospital, Boston, Massachusetts.
  • Liu M; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Muzikansky A; Department of Biostatistics Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Cardona J; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, Massachusetts.
  • Lou K; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, Massachusetts.
  • Beers AL; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, Massachusetts.
  • Chang K; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, Massachusetts.
  • Brown JM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ma X; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, Massachusetts.
  • Reardon DA; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, Massachusetts.
  • Arrillaga-Romany IC; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Forst DA; Stephen E. and Catherine Pappas Center for Neuro-Oncology Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Jordan JT; Stephen E. and Catherine Pappas Center for Neuro-Oncology Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Lee EQ; Stephen E. and Catherine Pappas Center for Neuro-Oncology Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Dietrich J; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Nayak L; Stephen E. and Catherine Pappas Center for Neuro-Oncology Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Giobbie-Hurder A; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Choi BD; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Batchelor TT; Department of Neurosurgery Massachusetts General Hospital, Boston, Massachusetts.
  • Kalpathy-Cramer J; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Curry WT; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, Massachusetts.
  • Gerstner ER; Department of Neurosurgery Massachusetts General Hospital, Boston, Massachusetts.
Clin Cancer Res ; 29(16): 3017-3025, 2023 Aug 15.
Article em En | MEDLINE | ID: mdl-37327319
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article